Halberd Corporation (HALB) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Jackson Center, PA, 미국. 현재 CEO는 William A. Hartman.
HALB 을(를) 보유 IPO 날짜 2012-09-25, 에 상장 Other OTC, 시가총액 $484.92K.
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
